{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T06:02:46Z","timestamp":1772690566034,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.clbc.2022.01.009","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T02:11:53Z","timestamp":1644286313000},"page":"e685-e690","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effect of a Novel Soaking Solution Used in Patients With Hand-Foot Syndrome as a Result of Capecitabine Treatment: A Randomized and Self-Controlled Trial"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0067-5588","authenticated-orcid":false,"given":"Yuxiu","family":"Xie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renwang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4100-5567","authenticated-orcid":false,"given":"Jing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2022.01.009_bib0001","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1177\/0091270004268321","article-title":"Hand-foot syndrome in patients treated with capecitabine-containing combination chemotherapy","volume":"44","author":"Heo","year":"2004","journal-title":"Journal of clinical pharmacology"},{"issue":"1","key":"10.1016\/j.clbc.2022.01.009_bib0002","first-page":"74","article-title":"Assessment of hand-foot syndrome in cancer outpatients undergoing chemotherapy","volume":"39","author":"Takeda","year":"2012","journal-title":"Gan to kagaku ryoho Cancer & chemotherapy"},{"key":"10.1016\/j.clbc.2022.01.009_bib0003","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1093\/annonc\/mdn389","article-title":"Hand foot skin reaction in cancer patients treated with the multikinase inhibitors sorafenib and sunitinib","volume":"19","author":"Lacouture","year":"2008","journal-title":"Annals of oncology : official journal of the European Society for Medical Oncology"},{"key":"10.1016\/j.clbc.2022.01.009_bib0004","doi-asserted-by":"crossref","first-page":"442","DOI":"10.4081\/oncol.2020.442","article-title":"Management of cytotoxic chemotherapy-induced hand-foot syndrome","volume":"14","author":"Kwakman","year":"2020","journal-title":"Oncol Rev"},{"key":"10.1016\/j.clbc.2022.01.009_bib0005","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.annonc.2020.11.005","article-title":"Prevention and Management of Dermatological Toxicities Related to Anticancer Agents: ESMO Clinical Practice Guidelines\u2020","volume":"32","author":"Lacouture","year":"2020","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.clbc.2022.01.009_bib0006","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ygyno.2004.05.027","article-title":"Oral dexamethasone attenuates Doxil-induced palmar-plantar erythrodysesthesias in patients with recurrent gynecologic malignancies","volume":"94","author":"Drake","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.clbc.2022.01.009_bib0007","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s12072-016-9774-x","article-title":"HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma","volume":"11","author":"Lin","year":"2017","journal-title":"Hepatol Int"},{"key":"10.1016\/j.clbc.2022.01.009_bib0008","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s40257-014-0107-3","article-title":"A review of vitamin B12 in dermatology","volume":"16","author":"Brescoll","year":"2015","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clbc.2022.01.009_bib0009","first-page":"173","article-title":"Effects of methylcobalamin (vitamin B12) on in vitro cytokine production of peripheral blood mononuclear cells","volume":"37","author":"Yamashiki","year":"1992","journal-title":"Journal of clinical & laboratory immunology"},{"key":"10.1016\/j.clbc.2022.01.009_bib0010","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1042\/CS20040134","article-title":"B-group vitamin supplementation mitigates oxidative damage after acute ischaemic stroke","volume":"107","author":"Ullegaddi","year":"2004","journal-title":"Clinical science (London, England : 1979)"},{"key":"10.1016\/j.clbc.2022.01.009_bib0011","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/0884533611405793","article-title":"Nutrition for brain recovery after ischemic stroke: an added value to rehabilitation","volume":"26","author":"Aquilani","year":"2011","journal-title":"Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition"},{"key":"10.1016\/j.clbc.2022.01.009_bib0012","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1365-2133.2004.05866.x","article-title":"Topical vitamin B12\u2013a new therapeutic approach in atopic dermatitis-evaluation of efficacy and tolerability in a randomized placebo-controlled multicentre clinical trial","volume":"150","author":"St\u00fccker","year":"2004","journal-title":"The British journal of dermatology"},{"key":"10.1016\/j.clbc.2022.01.009_bib0013","first-page":"321","article-title":"Antibiotic therapy in the management of atopic dermatitis","volume":"150","author":"Belloni Fortina","year":"2015","journal-title":"Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia"},{"key":"10.1016\/j.clbc.2022.01.009_bib0014","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jfma.2013.10.002","article-title":"Update on new medicinal applications of gentamicin: evidence-based review","volume":"113","author":"Chen","year":"2014","journal-title":"Journal of the Formosan Medical Association\u00a0=\u00a0Taiwan yi zhi"},{"issue":"1","key":"10.1016\/j.clbc.2022.01.009_bib0015","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.ejon.2004.06.007","article-title":"Management of hand-foot syndrome in patients treated with capecitabine (Xeloda)","volume":"8","author":"Lassere","year":"2004","journal-title":"European journal of oncology nursing : the official journal of European Oncology Nursing Society"},{"key":"10.1016\/j.clbc.2022.01.009_bib0016","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s12282-018-0879-z","article-title":"A randomized phase II study evaluating pyridoxine for the prevention of hand-foot syndrome associated with capecitabine therapy for advanced or metastatic breast cancer","volume":"25","author":"Toyama","year":"2018","journal-title":"Breast cancer (Tokyo, Japan)"},{"key":"10.1016\/j.clbc.2022.01.009_bib0017","first-page":"1585","article-title":"Prevention strategies for chemotherapy-induced hand-foot syndrome: a systematic review and meta-analysis of prospective randomized trials","volume":"22","author":"Macedo","year":"2014","journal-title":"Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer"},{"key":"10.1016\/j.clbc.2022.01.009_bib0018","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1001\/jamaoncol.2017.1269","article-title":"Predictors of Hand-Foot Syndrome and Pyridoxine for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized Clinical Trial","volume":"3","author":"Yap","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clbc.2022.01.009_bib0019","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1200\/JCO.2013.52.9651","article-title":"Randomized controlled trial of the prophylactic effect of urea-based cream on sorafenib-associated hand-foot skin reactions in patients with advanced hepatocellular carcinoma","volume":"33","author":"Ren","year":"2015","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.clbc.2022.01.009_bib0020","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1002\/ijc.31269","article-title":"Clinical evidence of prevention strategies for capecitabine-induced hand-foot syndrome","volume":"142","author":"Huang","year":"2018","journal-title":"International journal of cancer"},{"key":"10.1016\/j.clbc.2022.01.009_bib0021","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/annonc\/mdr400","article-title":"Celecoxib can prevent capecitabine-related hand-foot syndrome in stage II and III colorectal cancer patients: result of a single-center, prospective randomized phase III trial","volume":"23","author":"Zhang","year":"2012","journal-title":"Annals of oncology : official journal of the European Society for Medical Oncology"},{"issue":"12","key":"10.1016\/j.clbc.2022.01.009_bib0022","first-page":"31","article-title":"Effect of celecoxib on capecitabine-induced hand-foot syndrome and antitumor activity","volume":"16","author":"Lin","year":"2002","journal-title":"Oncology (Williston Park, NY)"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820922000258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820922000258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:23:38Z","timestamp":1761513818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820922000258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1526820922000258"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2022.01.009","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of a Novel Soaking Solution Used in Patients With Hand-Foot Syndrome as a Result of Capecitabine Treatment: A Randomized and Self-Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2022.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}